Life before seventeen: Cloning of the IL-17 receptor

Journal of Immunology

Volumn 187, Issue 9, 2011, Pages 4389-4391

  Gaffen, Sarah L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; CD40 ANTIGEN; COMPLEMENTARY DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR;

CELLULAR IMMUNITY; DNA LIBRARY; DNA VIRUS; FIBROBLAST; HERPES VIRUS SAIMIRI; HERPES VIRUS SAIMIRI 13; HUMAN; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOPROLIFERATIVE DISEASE; MOLECULAR CLONING; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS REPLICATION;

ANIMALS; HERPESVIRUS 2, SAIMIRIINE; HUMANS; INTERLEUKIN-17; RECEPTORS, INTERLEUKIN-17; REPRESSOR PROTEINS; TRANS-ACTIVATORS;

EID: 80555149932     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102576     Document Type: Review

References (49)

1. Bowie, A. G., and L. Unterholzner. 2008. Viral evasion and subversion of patternrecognition receptor signalling. Nat. Rev. Immunol. 8: 911-922.
2. Randall, R. E., and S. Goodbourn. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89: 1-47.
3. Rahman, M. M., A. R. Lucas, and G. McFadden. 2009. Viral TNF inhibitors as potential therapeutics. Adv. Exp. Med. Biol. 666: 64-77.
4. Rouvier, E., M.-F. Luciani, M.-G. Mattéi, F. Denizot, and P. Golstein. 1993. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a Herpesvirus saimiri gene. J. Immunol. 150: 5445-5456.
5. Yao, Z., W. C. Fanslow, M. F. Seldin, A.-M. Rousseau, S. L. Painter, M. R. Comeau, J. I. Cohen, and M. K. Spriggs. 1995. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3: 811-821. (Pubitemid 26091152)
6. Yao, Z., S. L. Painter, W. C. Fanslow, D. Ulrich, B. M. Macduff, M. K. Spriggs, and R. J. Armitage. 1995. Human IL-17: a novel cytokine derived from T cells. J. Immunol. 155: 5483-5486.
7. Aggarwal, S., and A. L. Gurney. 2002. IL-17: prototype member of an emerging cytokine family. J. Leukoc. Biol. 71: 1-8. (Pubitemid 34062767)
8. Moseley, T. A., D. R. Haudenschild, L. Rose, and A. H. Reddi. 2003. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14: 155-174.
9. Hymowitz, S. G., E. H. Filvaroff, J. P. Yin, J. Lee, L. Cai, P. Risser, M. Maruoka, W. Mao, J. Foster, R. F. Kelley, et al. 2001. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J. 20: 5332-5341. (Pubitemid 32959452)
10. Toy, D., D. Kugler, M. Wolfson, T. Vanden Bos, J. Gurgel, J. Derry, J. Tocker, and J. J. Peschon. 2006. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J. Immunol. 177: 36-39. (Pubitemid 43939112)
11. Ho, A. W., F. Shen, H. R. Conti, N. Patel, E. E. Childs, A. C. Peterson, N. Hernández-Santos, J. K. Kolls, L. P. Kane, W. Ouyang, and S. L. Gaffen. 2010. IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail. J. Immunol. 185: 1063-1070.
12. Hu, Y., N. Ota, I. Peng, C. J. Refino, D. M. Danilenko, P. Caplazi, and W. Ouyang. 2010. IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis. J. Immunol. 184: 4307-4316.
13. Ely, L. K., S. Fischer, and K. C. Garcia. 2009. Structural basis of receptor sharing by interleukin 17 cytokines. Nat. Immunol. 10: 1245-1251.
14. Novatchkova, M., A. Leibbrandt, J. Werzowa, A. Neubüser, and F. Eisenhaber. The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem. Sci. 28: 226-229.
15. Qian, Y., J. Qin, G. Cui, M. Naramura, E. C. Snow, C. F. Ware, R. L. Fairchild, S. A. Omori, R. C. Rickert, M. Scott, et al. 2004. Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. Immunity 21: 575-587. (Pubitemid 39370512)
16. Chang, S. H., H. Park, and C. Dong. 2006. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J. Biol. Chem. 281: 35603-35607. (Pubitemid 46041290)
17. Qian, Y., C. Liu, J. Hartupee, C. Z. Altuntas, M. F. Gulen, D. Jane-Wit, J. Xiao, Y. Lu, N. Giltiay, J. Liu, et al. 2007. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 8: 247-256. (Pubitemid 46745374)
18. Liu, C., W. Qian, Y. Qian, N. V. Giltiay, Y. Lu, S. Swaidani, S. Misra, L. Deng, Z. J. Chen, and X. Li. 2009. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling. Sci. Signal. 2: ra63.
19. Ryzhakov, G., K. Blazek, and I. A. Udalova. 2011. Evolution of vertebrate immunity: sequence and functional analysis of the SEFIR domain family member Act1. J. Mol. Evol. 72: 521-530.
20. Maitra, A., F. Shen, W. Hanel, K. Mossman, J. Tocker, D. Swart, and S. L. Gaffen. Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression. Proc. Natl. Acad. Sci. USA 104: 7506-7511.
21. Onishi, R., S. Park, W. Hanel, A. Maitra, and S. Gaffen. 2010. The SEFIR is not enough: An extended region downstream of the interleukin-17RA SEFIR domain is required for IL-17-dependent signal transduction. J. Biol. Chem. 285: 32751-32759.
22. Rickel, E. A., L. A. Siegel, B. R. Yoon, J. B. Rottman, D. G. Kugler, D. A. Swart, P. M. Anders, J. E. Tocker, M. R. Comeau, and A. L. Budelsky. 2008. Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25- induced activities. J. Immunol. 181: 4299-4310.
23. Gaffen, S. L. 2009. Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. 9: 556-567.
24. Iwakura, Y., H. Ishigame, S. Saijo, and S. Nakae. 2011. Functional specialization of interleukin-17 family members. Immunity 34: 149-162.
25. Hsu, H. C., P. Yang, J. Wang, Q. Wu, R. Myers, J. Chen, J. Yi, T. Guentert, A. Tousson, A. L. Stanus, et al. 2008. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat. Immunol. 9: 166-175.
26. Doreau, A., A. Belot, J. Bastid, B. Riche, M. C. Trescol-Biemont, B. Ranchin, N. Fabien, P. Cochat, C. Pouteil-Noble, P. Trolliet, et al. 2009. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat. Immunol. 10: 778-785.
27. Knappe, A., C. Hiller, H. Niphuis, F. Fossiez, M. Thurau, S. Wittmann, E. M. Kuhn, S. Lebecque, J. Banchereau, B. Rosenwirth, et al. 1998. The interleukin-17 gene of herpesvirus saimiri. J. Virol. 72: 5797-5801. (Pubitemid 28283365)
28. Roberts, S., Y. Gueguen, J. de Lorgeril, and F. Goetz. 2008. Rapid accumulation of an interleukin 17 homolog transcript in Crassostrea gigas hemocytes following bacterial exposure. Dev. Comp. Immunol. 32: 1099-1104.
29. Tsutsui, S., O. Nakamura, and T. Watanabe. 2007. Lamprey (Lethenteron japonicum) IL-17 upregulated by LPS-stimulation in the skin cells. Immunogenetics 59: 873-882. (Pubitemid 350160027)
30. Pancer, Z., W. E. Mayer, J. Klein, and M. D. Cooper. 2004. Prototypic T cell receptor and CD4-like coreceptor are expressed by lymphocytes in the agnathan sea lamprey. Proc. Natl. Acad. Sci. USA 101: 13273-13278. (Pubitemid 39209655)
31. Tsang, M., R. Friesel, T. Kudoh, and I. B. Dawid. 2002. Identification of Sef, a novel modulator of FGF signalling. Nat. Cell Biol. 4: 165-169. (Pubitemid 34141484)
32. Steinman, L. 2007. A brief history of T(H)17, the first major revision in the T(H) 1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat. Med. 13: 139-145.
33. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141. (Pubitemid 41541791)
34. Harrington, L. E., R. D. Hatton, P. R. Mangan, H. Turner, T. L. Murphy, K. M. Murphy, and C. T. Weaver. 2005. Interleukin 17-producing CD41 effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132. (Pubitemid 41541790)
35. Korn, T., E. Bettelli, M. Oukka, and V. K. Kuchroo. 2009. IL-17 and Th17 cells. Annu. Rev. Immunol. 27: 485-517.
36. Cua, D. J., and C. M. Tato. 2010. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 10: 479-489.
37. Kolls, J. K., and A. Lindén. 2004. Interleukin-17 family members and inflammation. Immunity 21: 467-476. (Pubitemid 39370503)
38. Yu, J. J., and S. L. Gaffen. 2008. Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front. Biosci. 13: 170-177. (Pubitemid 351594768)
39. Ye, P., F. H. Rodriguez, S. Kanaly, K. L. Stocking, J. Schurr, P. Schwarzenberger, P. Oliver, W. Huang, P. Zhang, J. Zhang, et al. 2001. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194: 519-527. (Pubitemid 32835046)
40. Peck, A., and E. D. Mellins. 2010. Precarious balance: Th17 cells in host defense. Infect. Immun. 78: 32-38.
41. Puel, A., C. Picard, S. Cypowyj, D. Lilic, L. Abel, and J. L. Casanova. 2010. Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines? Curr. Opin. Immunol. 22: 467-474.
42. Puel, A., S. Cypowyj, J. Bustamante, J. F. Wright, L. Liu, H. K. Lim, M. Migaud, L. Israel, M. Chrabieh, M. Audry, et al. 2011. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332: 65-68.
43. Holland, S. M., F. R. DeLeo, H. Z. Elloumi, A. P. Hsu, G. Uzel, N. Brodsky, A. F. Freeman, A. Demidowich, J. Davis, M. L. Turner, et al. 2007. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 357: 1608-1619. (Pubitemid 47598403)
44. Schwarzenberger, P., and J. K. Kolls. 2002. Interleukin 17: an example for gene therapy as a tool to study cytokine mediated regulation of hematopoiesis. J. Cell. Biochem. Suppl. 38: 88-95. (Pubitemid 34477671)
45. Conti, H. R., F. Shen, N. Nayyar, E. Stocum, J. N. Sun, M. J. Lindemann, A. W. Ho, J. H. Hai, J. J. Yu, J. W. Jung, et al. 2009. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 206: 299-311.
46. Kagami, S., H. L. Rizzo, S. E. Kurtz, L. S. Miller, and A. Blauvelt. 2010. IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans. J. Immunol. 185: 5453-5462.
47. Cho, J. S., E. M. Pietras, N. C. Garcia, R. I. Ramos, D. M. Farzam, H. R. Monroe, J. E. Magorien, A. Blauvelt, J. K. Kolls, A. L. Cheung, et al. 2010. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J. Clin. Invest. 120: 1762-1773.
48. Hueber, W., D. D. Patel, T. Dryja, A. M. Wright, I. Koroleva, G. Bruin, C. Antoni, Z. Draelos, M. H. Gold, P. Durez, et al. 2010. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci. Transl. Med. 2:52ra72.
49. Genovese, M. C., F. Van den Bosch, S. A. Roberson, S. Bojin, I. M. Biagini, P. Ryan, and J. Sloan-Lancaster. 2010. LY2439821, a humanized anti-interleukin- 17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum. 62: 929-939.